ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 132 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,476 | -28.1% | 2,715,599 | +1.2% | 0.01% | -27.3% |
| Q2 2023 | $75,726 | +100.1% | 2,684,352 | +22.0% | 0.01% | +83.3% |
| Q1 2023 | $37,844 | -13.7% | 2,200,169 | +1.1% | 0.01% | -14.3% |
| Q4 2022 | $43,839 | -99.9% | 2,176,700 | -1.9% | 0.01% | -12.5% |
| Q3 2022 | $48,037,000 | -60.2% | 2,217,740 | -48.4% | 0.01% | -46.7% |
| Q2 2022 | $120,789,000 | -37.6% | 4,298,551 | +2.4% | 0.02% | -25.0% |
| Q1 2022 | $193,704,000 | -47.4% | 4,198,180 | -4.2% | 0.02% | -39.4% |
| Q4 2021 | $368,425,000 | +48.2% | 4,382,881 | +17.5% | 0.03% | +43.5% |
| Q3 2021 | $248,596,000 | +43.4% | 3,730,425 | +14.4% | 0.02% | +43.8% |
| Q2 2021 | $173,409,000 | +268.6% | 3,259,568 | +200.6% | 0.02% | +220.0% |
| Q1 2021 | $47,045,000 | -17.2% | 1,084,246 | -0.9% | 0.01% | -16.7% |
| Q4 2020 | $56,824,000 | +57.2% | 1,094,026 | -1.1% | 0.01% | +50.0% |
| Q3 2020 | $36,156,000 | -36.6% | 1,106,020 | -6.9% | 0.00% | -42.9% |
| Q2 2020 | $57,027,000 | – | 1,187,566 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |